Anaphylactoid reactions to radiocontrast media

Allergy and Asthma Proceedings

Volumn 26, Issue 3, 2005, Pages 199-203

  Canter, Lauren M ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CONTRAST MEDIUM;

ANAPHYLAXIS; CHEMICALLY INDUCED DISORDER; HUMAN; PREMEDICATION; REVIEW;

ANAPHYLAXIS; CONTRAST MEDIA; HUMANS; PREMEDICATION;

EID: 24944550436     PISSN: 10885412     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (28)

1. Brooks B. Intra-arterial injection of sodium iodide. JAMA 82:1016-1019, 1924.
2. Lieberman PL, and Seigle RL. Reactions to radiocontrast material: Anaphylactoid events in radiology. Clin Rev Allergy Immunol 17: 469-496, 1999.
3. Grainger RG. Intravascular radiological iodinated contrast media. In Diagnostic Radiology: A Textbook of Medical Imaging, 4th ed. Grainger RG, Allison D, Adam A, and Dixon AK (Eds). London: W.B. Saunders, 27-41, 2001.
4. Courvoisier S. and Bircher AJ. Delayed-type hypersensitivity to a nonionic, radiopaque contrast medium. Allergy 53:1221-1224, 1998.
5. American College of Radiology Committee on Drugs and Contrast Media. ACR Manual on Contrast Media, 5th ed. Reston, VA: American College of Radiology, 5-77, 2004.
6. Hagan JB. Anaphylactoid and adverse reactions to radiocontrast agents. Immunol Allergy Clin North Am 24:507-519, 2004.
7. Katayama H, Yamaguchi K, Kozuka T, et al. Adverse reactions to ionic and nonionic contrast media. Radiology 175:621-628, 1990.
8. Kumar S, and Mahalingam R. Anaphylactoid reactions to radiocontrast agents. Ped Rev 22:356, 2001.
9. Lawrence V, Matthai W, and Hartmaier S. Comparative safety of high-osmolality and low-osmolality radiographic contrast agents: Report of a multidisciplinary working group. Invest Radiol 27:2-28, 1992.
10. Barrett BJ, Parfrey PS, McDonald JR, et al. Nonionic low-osmolality versus ionic high-osmolality contrast material for intravenous use in patients perceived to be at high risk: Randomized trial. Radiology 183:105-110, 1992.
11. Marshall GD Jr, and Lieberman PL. Comparison of three pretreatment protocols to prevent anaphylactoid reactions to radiocontrast media. Ann Allergy 67:70-74, 1991.
12. Brockow K, Vieluf D, Puschel K, et al. Increased postmortem serum mast cell tryptase in a fatal anaphylactoid reaction to nonionic radiocontrast medium. J Allergy Clin Immunol 104:237-238, 1999.
13. Cashman JD, McCredie J, and Henry DA. Intravenous contrast media: Use and associated mortality. Med J Aust 155:618-623, 1991.
14. Lasser EC, Lyon SG, and Berry CC. Reports on contrast media reactions: Analysis of data from reports to the US Food and Drug Administration. Radiology 203:605-610, 1997.
15. Bettmann MA, Heeren T, Greenfield A, and Goudey C. Adverse events with radiographic contrast agents: Results of the SCVIR contrast agent registry. Radiology 203:611-620, 1997.
16. Lang DM, Alpern MB, Visintainer PF, and Smith ST. Elevated risk of anaphylactoid reaction from radiographic contrast media is associated with both β-blocker exposure and cardiovascular disorders. Arch Intern Med 153:2033-2040, 1993.
17. Littner MR, Ulreich S, Putman CE, et al. Bronchospasm during excretory urography: Lack of specificity for the methylglucamine cation. Am J Roentgenol 137:477-481, 1981.
18. Lang DM, Alpern MB, Visintainer PF, and Smith ST. Gender risk for anaphylactoid reaction to radiographic contrast media. J Allergy Clin Immunol 95:813-817, 1995.
19. Ring J, Arroyave CM, Frizler MJ, and Tan EM. In vitro histamine and serotonin release by radiographic contrast media (RCM). Complement-dependent and -independent release reaction and changes in ultrastructure of human blood cells. Clin Exp Immunol 32:105-112, 1978.
20. Genovese A, Stellato C, Patella V, et al. Contrast media are incomplete secretagogues acting on human basophils and mast cells isolated from heart and lung, but not skin tissue. Int J Clin Lab Res 26:192-198, 1996.
21. Banks JR, Kagey-Sobotka A, Lichtenstein LM, and Eggleston PA. Spontaneous histamine release after exposure to hyperosmolar solutions. J Allergy Clin Immunol 78:51-57, 1986.
22. Szebeni J. Hypersensitivity reactions to radiocontrast media: The role of complement activation. Curr Allergy Asthma Rep 4:25-30, 2004.
23. Kanny G, Maria Y, Mentre B, and Moneret-Vautrin DA. Case report: Recurrent anaphylactic shock to radiographic contrast media. Evidence supporting an exceptional IgE-mediated reaction. Allergy Immunol 25:425-430, 1993.
24. Sidhu PS, and Dawson P. Adverse reactions to contrast media. In Textbook of Contrast Media. Dawson P, Cosgrove DO, and Grainger RG (Eds). Oxford: ISIS Medical Media, 99-119, 1999.
25. Brockow K, Becker EW, Worret WI, and Ring J. Late skin test reactions to radiocontrast medium. J Allergy Clin Immunol 104: 1107-1108, 1999.
26. Valls C, Andia E, Sanchez A, and Moreno V. Selective use of low-osmolality contrast media in computed tomography. Eur Radiol 13:2000-2005, 2003.
27. 2-receptor antagonists. Results of a prospective controlled trial. Int Arch Allergy Appl Immunol 78:9-14, 1985.
28. Greenberger P, Patterson R, and Radin RC. Two pretreatment regimens for high risk patients receiving radiographic contrast media. J Allergy Clin Immunol 74:540-543, 1984.